Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) Net Margin (2016 - 2025)

Historic Net Margin for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to 23.61%.

  • Select Medical Holdings' Net Margin fell 285000.0% to 23.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.37%, marking a year-over-year decrease of 228000.0%. This contributed to the annual value of 1.58% for FY2024, which is 12400.0% down from last year.
  • Select Medical Holdings' Net Margin amounted to 23.61% in Q3 2025, which was down 285000.0% from 24.17% recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Net Margin ranged from a high of 99.21% in Q4 2022 and a low of 24.17% during Q2 2025
  • Its 5-year average for Net Margin is 3.05%, with a median of 4.25% in 2021.
  • As far as peak fluctuations go, Select Medical Holdings' Net Margin soared by 949600bps in 2022, and later tumbled by -1179100bps in 2023.
  • Quarter analysis of 5 years shows Select Medical Holdings' Net Margin stood at 4.25% in 2021, then skyrocketed by 2234bps to 99.21% in 2022, then tumbled by -119bps to 18.71% in 2023, then fell by -19bps to 22.2% in 2024, then fell by -6bps to 23.61% in 2025.
  • Its Net Margin stands at 23.61% for Q3 2025, versus 24.17% for Q2 2025 and 23.47% for Q1 2025.